Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy

Overview of attention for article published in Allergy, January 2026

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 4 public wall posts from 1 users.

Allergy provides the readers with 26 free and open access articles in the August issue! Check out the articles and download…

📅 This Week in Allergy 📚 Missed our latest content? Here's your weekend catch-up: ✅ Open Access: Development of Betalactam-Pr…

Open Access: Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients.

Marina Labella from the Hospital Regional Universitario de Málaga, Málaga, Spain, presents their research findings published in…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.